A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

Published:2000-03 Issue:3 Volume:27 Page:145-157
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Roszkowski Kazimierz,Pluzanska Anna,Krzakowski Maciej,Smith Alexander Peter,Saigi Eugeni,Aasebo Ulf,Parisi Annamaria,Pham Tran Ngoc,Olivares Robert,Berille Jocelyne

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology;Aaronson;J. Natl. Cancer Inst.,1993

2. Proceedings/Program ASCO (American Society of Clinical Oncology). Thirtyfifth annual meeting, vol. 18, May 15–18, 1999. Atlanta.

3. American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol 1997;15:2996–3018.

4. Anderson H, Cottier B, Nicolson M, et al. Phase III study of gemcitabine (Gemzar®) versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC) [abstract]. Lung Cancer 1997;18(1):9. Abstract 24 and oral presentation in Dublin, Ireland, 1997.

5. Further evidence in favour of chemotherapy for inoperable non small cell lung cancer;Buccheri;Lung Cancer,1990

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status;Cochrane Database of Systematic Reviews;2023-07-07

2. Novel imidazo[1,2-a]pyridine derivatives induce apoptosis and cell cycle arrest in non-small cell lung cancer by activating NADPH oxidase mediated oxidative stress;Life Sciences;2022-04

3. Epidemiological Study of Lung Cancer and Clinical Medication in England from 2001 to 2019;Journal of Healthcare Engineering;2022-03-23

4. The need for speed in advanced non‐small cell lung cancer: A population kinetics assessment;Cancer Medicine;2021-11-11

5. Virtual randomized study comparing lobectomy and particle beam therapy for clinical stage IA non-small cell lung cancer in operable patients;Journal of Radiation Research;2021-07-05